久久久久一级片-国产69久久精品成人看-欧美日韩精品一区二区三区-日韩精品午夜

當前位置:產品中心 > 抗體 > Biosimilar抗體 > Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)
Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)
基本信息

產品編號:GM-26560AB

產品名稱:Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)

目錄價:詢價


產品配圖.jpg


規格貨號

GM-26560AB-10          10 μg

GM-26560AB-100        100 μg

GM-26560AB-1000      1mg


產品簡介


Species Reactivity      Human; Cynomolgus

Clone                          Rovalpituzumab

Source/Isotype           Monoclonal Human IgG1 /κ

Application                 Flow Cytometry

Specificity                   Detects DLL3

Gene                            DLL3

Other Names              SCDO1

Gene ID                       Q9NYJ7 (Human); A0A2K5WSR1-1 (Cynomolgus)

Background                Delta-like 3 (Drosophila), also known as DLL3, is a protein which in humans is encoded by the DLL3 gene. This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Expression of DLL3 is highest in fetal brain. It plays a key role in somitogenesis within the Paraxial mesoderm. Mutations in this gene cause the autosomal recessive genetic disorder Jarcho-Levin syndrome. Expression of the gene occurs in Neuroendocrine tumors, which has been targeted as a potential pathway for treatment. An experimental drug, rovalpituzumab tesirine, targets DLL3 as a possible treatment for lung cancer.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2.

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay


數據展示

/ueditor/image/20240515/1715762743945960/fd0532fb6e729259625cdc4e3d36d063.png

/ueditor/image/20240515/1715762766667209/7dc8caf97ca02825bdd775242a7b4884.png


當前位置:產品中心 > 抗體 > Biosimilar抗體 > Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)

Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)
基本信息

產品編號:GM-26560AB

產品名稱:Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)

目錄價:詢價


產品配圖.jpg


規格貨號

GM-26560AB-10          10 μg

GM-26560AB-100        100 μg

GM-26560AB-1000      1mg


產品簡介


Species Reactivity      Human; Cynomolgus

Clone                          Rovalpituzumab

Source/Isotype           Monoclonal Human IgG1 /κ

Application                 Flow Cytometry

Specificity                   Detects DLL3

Gene                            DLL3

Other Names              SCDO1

Gene ID                       Q9NYJ7 (Human); A0A2K5WSR1-1 (Cynomolgus)

Background                Delta-like 3 (Drosophila), also known as DLL3, is a protein which in humans is encoded by the DLL3 gene. This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Expression of DLL3 is highest in fetal brain. It plays a key role in somitogenesis within the Paraxial mesoderm. Mutations in this gene cause the autosomal recessive genetic disorder Jarcho-Levin syndrome. Expression of the gene occurs in Neuroendocrine tumors, which has been targeted as a potential pathway for treatment. An experimental drug, rovalpituzumab tesirine, targets DLL3 as a possible treatment for lung cancer.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2.

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay


數據展示

/ueditor/image/20240515/1715762743945960/fd0532fb6e729259625cdc4e3d36d063.png

/ueditor/image/20240515/1715762766667209/7dc8caf97ca02825bdd775242a7b4884.png


Tel: 400-627-9288
留言咨詢
重置
提交
客服
微信
電話
留言
留言咨詢
重置
提交